Resultats globals: 10 registres trobats en 0.02 segons.
Articles, 9 registres trobats
Documents de recerca, 1 registres trobats
Articles 9 registres trobats  
1.
7 p, 280.3 KB Effectiveness of treatment with nebulized colistin in patients with COPD / Bruguera-Avila, Nuria (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Marin, Alicia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Garcia-Olive, Ignasi (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Radua, Joaquim (Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden) ; Prat, Cristina (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Gil, Montserrat (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Ruiz-Manzano, Juan (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
To analyze whether the introduction of nebulized colistin in patients with chronic obstructive pulmonary disease (COPD) and infection with Pseudomonas aeruginosa (PA) is associated with a decrease of the number and duration of severe exacerbations. [...]
2017 - 10.2147/COPD.S138428
International Journal of Chronic Obstructive Pulmonary Disease, Vol. 12 (october 2017) , p. 2909-2915  
2.
5 p, 342.0 KB Specific IgA against Pseudomonas aeruginosa in severe COPD / Millares, Laura (Fundació Parc Taulí. Departament de Pneumologia) ; Martí, Sara (Universitat de Barcelona-IDIBELL. Hospital Universitari de Bellvitge. Departament de Microbiologia) ; Ardanuy, Carmen (Universitat de Barcelona-IDIBELL. Hospital Universitari de Bellvitge. Departament de Microbiologia) ; Liñares, Josefina (Universitat de Barcelona-IDIBELL. Hospital Universitari de Bellvitge. Departament de Microbiologia) ; Santos, Salud (Universitat de Barcelona-IDIBELL. Hospital Universitari de Bellvitge. Departament de Pneumologia) ; Dorca, Jordi (Universitat de Barcelona-IDIBELL. Hospital Universitari de Bellvitge. Departament de Pneumologia) ; García-Nuñez, Marian (Fundació Parc Taulí. Departament de Pneumologia) ; Quero, Sara (Institut Germans Trias i Pujol) ; Monsó, Eduard (Fundació Parc Taulí. Departament de Pneumologia) ; Universitat Autònoma de Barcelona. Departament de Medicina
The bronchial mucosa is protected by a specialized immune system focused on the prevention of colonization and infection by potentially pathogenic microorganisms (PPMs). Immunoglobulin A (IgA) is the principal antibody involved in this mechanism. [...]
2017 - 10.2147/COPD.S141701
International journal of chronic obstructive pulmonary disease, Vol. 12 (September 2017) , p. 2807-2811  
3.
8 p, 317.9 KB Effect of a rehabilitation-based chronic disease management program targeting severe COPD exacerbations on readmission patterns / Lalmolda, Cristina (Universitat Autònoma de Barcelona) ; Coll Fernández, Roser (Corporació Sanitària Parc Taulí. Departament de Rehabilitació) ; Martínez, Natalia (Corporació Sanitària Parc Taulí. Departament de Malalties Respiratòries) ; Baré i Mañas, Marisa (Institut Català de la Salut. Servei d'Atenció Primària Vallès Occidental) ; Teixidó Colet, M (Institut Català de la Salut. Servei d'Atenció Primària Vallès Occidental) ; Epelde, F (Corporació Sanitària Parc Taulí. Servei d'Emergències) ; Monsó, E (Universitat Autònoma de Barcelona)
Pulmonary rehabilitation (PR) is recommended after a severe COPD exacerbation, but its short- and long-term effects on health care utilization have not been fully established. The aims of this study were to evaluate patient compliance with a chronic disease management (CDM) program incorporating home-based exercise training as the main component after a severe COPD exacerbation and to determine its effects on health care utilization in the following year. [...]
2017 - 10.2147/COPD.S138451
International journal of chronic obstructive pulmonary disease, Vol. 12 (2017) , p. 2531-2538  
4.
9 p, 678.3 KB Palliative care and prognosis in COPD : a systematic review with a validation cohort / Almagro, Pere (Multimorbidity Patients Unit, Internal Medicine Department, Hospital Universitario Mutua de Terrassa, Universidad de Barcelona, Terrassa, Barcelona) ; Yun, Sergi (Multimorbidity Patients Unit, Internal Medicine Department, Hospital Universitario Mutua de Terrassa, Universidad de Barcelona, Terrassa, Barcelona) ; Sangil, Ana (Multimorbidity Patients Unit, Internal Medicine Department, Hospital Universitario Mutua de Terrassa, Universidad de Barcelona, Terrassa, Barcelona) ; Rodríguez-Carballeira, Mónica (Multimorbidity Patients Unit, Internal Medicine Department, Hospital Universitario Mutua de Terrassa, Universidad de Barcelona, Terrassa, Barcelona) ; Marine, Meritxell (Multimorbidity Patients Unit, Internal Medicine Department, Hospital Universitario Mutua de Terrassa, Universidad de Barcelona, Terrassa, Barcelona) ; Landete, Pedro (Department of Pneumology, Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, Madrid) ; Soler-Cataluña, Juan José (Department of Pneumology, Hospital Arnau de Vilanova-Lliria, Valencia) ; Soriano, Joan B (Instituto de Investigación Hospital Universitario de la Princesa (IISP), Universidad Autónoma de Madrid, Madrid) ; Miravitlles, Marc (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Current recommendations to consider initiation of palliative care (PC) in COPD patients are often based on an expected poor prognosis. However, this approach is not evidence-based, and which and when COPD patients should start PC is controversial. [...]
2017 - 10.2147/COPD.S135657
International journal of chronic obstructive pulmonary disease, Vol. 12 (june 2017) , p. 1721-1729  
5.
8 p, 438.4 KB Characteristics of COPD patients initiating treatment with aclidinium or tiotropium in primary care in Catalonia : a population-based study / Monteagudo Zaragoza, Mònica (Universitat Autònoma de Barcelona) ; Roset, Montse (IMS Health) ; Rodríguez Blanco, Teresa (Universitat Autònoma de Barcelona) ; Muñoz Ortiz, Laura (Agència de Qualitat i Avaluació Sanitàries de Catalunya) ; Miravitlles, Marc (Hospital Universitari Vall d'Hebron)
To describe and compare demographic and clinical profile of patients newly initiated on aclidinium (ACL) or tiotropium (TIO) and identify factors associated with newly initiated ACL in real-life clinical practice during 2013 in Catalonia. [...]
2017 - 10.2147/COPD.S131016
International journal of chronic obstructive pulmonary disease, Vol. 12 (April 2017) , p. 1145-1152  
6.
11 p, 303.7 KB Treatment of patients with COPD and recurrent exacerbations : the role of infection and inflammation / Santos, Salud (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain) ; Marin, Alicia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Serra-Batlles, Joan (Hospital Universitari de Vic) ; de la Rosa, David (Hospital Plató) ; Solanes, Ingrid (Institut d'Investigació Biomèdica Sant Pau) ; Pomares, Xavier (Hospital Universitari Parc Taulí) ; López-Sánchez, Marta (Hospital Universitari de Bellvitge) ; Muñoz-Esquerre, Mariana (Hospital Universitari de Bellvitge) ; Miravitlles, Marc (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Exacerbations of COPD represent an important medical and health care problem. Certain susceptible patients suffer recurrent exacerbations and as a consequence have a poorer prognosis. The effects of bronchial infection, either acute or chronic, and of the inflammation characteristic of the disease itself raise the question of the possible role of antibiotics and anti-inflammatory agents in modulating the course of the disease. [...]
2016 - 10.2147/COPD.S98333
International journal of chronic obstructive pulmonary disease, Vol. 11 (march 2016) , p. 515-525  
7.
10 p, 374.7 KB What pulmonologists think about the asthma-COPD overlap syndrome / Miravitlles, Marc (CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain) ; Alcázar, Bernardino (Respiratory Department, Hospital de Alta Resolucion de Loja) ; Alvarez, Francisco Javier (Hospital Universitario Virgen del Rocío) ; Bazús, Teresa (Hospital Universitario Central de Asturias) ; Calle, Myriam (Hospital Clínico San Carlos, Madrid) ; Casanova, Ciro (Hospital Nuestra Señora de la Candelaria, Santa Cruz de Tenerife) ; Cisneros, Carolina (Instituto de Investigación Sanitaria (IIS-IP), Madrid) ; de-Torres, Juan P (Clínica Universidad de Navarra, Pamplona) ; Entrenas, Luis M (Hospital Universitario Reina Sofia, Córdoba) ; Esteban, Cristóbal (Hospital Galdakao-Usansolo, Galdakao) ; García-Sidro, Patricia (Hospital Universitario de La Plana, Vila-real) ; Cosio, Borja G (Hospital Universitario Son Espases IdISPa, Palma de Mallorca) ; Huerta, Arturo (Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)) ; Iriberri, Milagros (Hospital Universitario de Cruces, Bilbao) ; Izquierdo, José Luis (Hospital Universitario de Guadalajara) ; López-Viña, Antolín (Hospital Universitario Puerta de Hierro Majadahonda) ; López-Campos, José Luis (Hospital Universitario Virgen del Rocío) ; Martínez-Moragón, Eva (Hospital Universitario Dr Peset, Valencia) ; Pérez de Llano, Luis (Hospital Universitario Lucus Augusti, Lugo) ; Perpiñá, Miguel (Hospital Universitario y Politécnico La Fe, Valencia) ; Ros, José Antonio (Hospital Clínico Universitario Virgen de la Arrinxaca, Murcia) ; Serrano, José (Hospital Comarcal de Inca) ; Soler-Cataluña, Juan José (Hospital Arnau de Vilanova-Lliria, Valencia) ; Torrego, Alfons (Institut d'Investigació Biomèdica Sant Pau) ; Urrutia, Isabel (Hospital Galdakao-Usansolo, Galdakao) ; Plaza, Vicente (Institut d'Investigació Biomèdica Sant Pau)
Some patients with COPD may share characteristics of asthma; this is the so-called asthma-COPD overlap syndrome (ACOS). There are no universally accepted criteria for ACOS, and most treatments for asthma and COPD have not been adequately tested in this population. [...]
2015 - 10.2147/COPD.S88667
International journal of chronic obstructive pulmonary disease, Vol. 10 (july 2015) , p. 1321-1330  
8.
10 p, 619.3 KB Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial / Rottenkolber, Marietta (Institute for Medical Information Sciences, Biometry, and Epidemiology, Ludwig-Maximilians-Universitaet) ; Fischer, Rainald (Pneumologische Praxis Muenchen - Pasing, Munich, Germany) ; Ibáñez, Luisa (Universitat Autaònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Fortuny, Joan (Novartis Farmaceutica SA) ; Reynolds, Robert (Pfizer Research & Development, New York, USA) ; Amelio, Justyna (Amgen Ltd, Uxbridge, UK) ; Gerlach, Roman (National Association of Statutory Health Insurance Physicians of Bavaria, Munich, Germany) ; Tauscher, Martin (National Association of Statutory Health Insurance Physicians of Bavaria, Munich, Germany) ; Thürmann, Petra (Philipp Klee-Institute for Clinical Pharmacology, HELIOS Clinic Wuppertal, Wuppertal, Germany) ; Hasford, Joerg (Institute for Medical Information Sciences, Biometry, and Epidemiology, Ludwig-Maximilians-Universitaet) ; Schmiedl, Sven (Philipp Klee-Institute for Clinical Pharmacology, HELIOS Clinic Wuppertal, Wuppertal, Germany)
After the SMART trial evaluating the safety of salmeterol (long-acting beta-2-agonist (LABA)) in asthma patients, regulatory actions were taken to promote a guideline-adherent prescribing of LABA only to patients receiving inhaled corticosteroids (ICS). [...]
2015 - 10.1186/s12890-015-0051-x
BMC Pulmonary Medicine, Vol. 15 (may 2015)  
9.
17.3 KB Lights and shadows of non-invasive mechanical ventilation for chronic obstructive pulmonary disease (COPD) exacerbations / Lopez-Campos, Jose Luis (Instituto de Salud Carlos III. Centro de Investigación en Red de Enfermedades Respiratorias) ; Jara-Palomares, Luis (Hospital Universitario Virgen del Rocío. Instituto de Biomedicina de Sevilla) ; Muñoz, Xavier (Hospital Universitari Vall d'Hebron. Servei de Pneumologia) ; Bustamante, Víctor (EHU. Departamento de Medicina) ; Barreiro, Esther (Institut Hospital del Mar d'Investigacions Mèdiques) ; Universitat Autònoma de Barcelona
Despite the overwhelming evidence justifying the use of non-invasive ventilation (NIV) for providing ventilatory support in chronic obstructive pulmonary disease (COPD) exacerbations, recent studies demonstrated that its application in real-life settings remains suboptimal. [...]
2015 - 10.4103/1817-1737.151440
Annals of Thoracic Medicine, Vol. 10 (2015) , p. 87-93  

Documents de recerca 1 registres trobats  
1.
114 p, 6.2 MB Influencia de la exposición ocupacional en la enfermedad pulmonar obstructiva crónica / Rodríguez González, Esther ; Ferrer Sancho, Jaume, 1958-, dir. ; Zock, Jan -Paul, dir. ; Universitat Autònoma de Barcelona. Departament de Medicina
La enfermedad pulmonar obstructiva crónica (EPOC) es una enfermedad que se caracteriza por una obstrucción no reversible al flujo aéreo, progresiva y asociada a una reacción inflamatoria anómala secundaria a la inhalación de gases o partículas nocivas, y producida sobre todo por el humo del tabaco. [...]
Chronic Obstructive Pulmonary Disease (COPD) is a lung disease characterized by a not reversible and progressive airflow limitation associated with an anomalous inflammatory reaction produced by inhalation of gases (and fumes) or toxic particles, and mostly caused by tobacco smoke. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2015  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.